Retension Pharmaceuticals is a biopharmaceutical company focused on developing treatments for cardiovascular health. The company concentrates its research and development efforts on optimizing blood pressure management. Their work aims to advance therapeutic options within the cardiovascular disease space.
Funding
Funding not disclosed
Founders
Product
Problem
Elevated blood pressure affects nearly 50% of adult Americans, increasing the risk of cardiovascular diseases. Current treatments may not be optimal for all patients, highlighting the need for more targeted and effective therapies.
Solution
Retension Pharmaceuticals is developing biopharmaceutical therapies designed to optimize blood pressure and improve overall cardiovascular health. The company focuses on creating targeted solutions to address the unmet needs of individuals with elevated blood pressure. By developing innovative treatments, Retension Pharmaceuticals aims to provide clinicians with more effective tools to manage blood pressure and reduce the incidence of cardiovascular events. Their research and development efforts are centered on identifying novel therapeutic targets and developing precision medicines that can improve patient outcomes.
Target Audience
The primary target audience includes individuals with elevated blood pressure and healthcare providers specializing in cardiovascular health.
Features
- Development of biopharmaceutical therapies for blood pressure management
- Focus on targeted solutions for specific patient populations
- Research and development of novel therapeutic targets
- Precision medicine approach to improve patient outcomes